NCT Number: NCT00212706
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
The purpose of this study is to evaluate the efficacy and safety of ONO-8025 (KRP-197) in patients with overactive bladder.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients who are 20 years old or over with overactive bladder
- Total number of urinary incontinence episodes per week is 5 or over
- Mean number of micturition per day is 8 or over
- Mean number of urinary urgency episodes per day is 1 or over
- Other inclusion criteria as specified in the study protocol
Exclusion criteria
- Patients with genuine stress incontinence
- Patients suffering from complications such as bladder tumor, bladder stone and urinary tract infection
- Patients who have undergone surgical operation of urinary and/or genital organs within 6 months prior to the study
- Patients suffering from complications for which anticholinergics are contraindicated
- Other exclusion criteria as specified in the study protocol
Treatment and study plan
Primary outcomes
-
Total number of urinary incontinence episodes per week
Secondary outcomes
-
Number of micturition per day, number of urinary urgency episodes per day, volume voided per micturition and QOL
Sponsors and collaborators
Lead sponsor
Ono Pharmaceutical Co., Ltd.
Industry
Registry information
Important dates
- Study start
- 2001
- Primary completion
- 2002
- First posted
- Sep 21, 2005
- Registry last updated
- Oct 12, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
NCT05799313
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cleveland, Ohio, United States
View Trial DetailsUrinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks
NCT05557279
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Maywood, Illinois, United States
View Trial DetailsrTMS in Overactive Bladder
NCT06198439
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Houston, Texas, United States
View Trial DetailsEffect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
NCT06206512
Cardiovascular Diseases, Female Urogenital Diseases
Dallas, Texas, United States
View Trial Details